Literature DB >> 15951829

Amiloride protects against pentylenetetrazole-induced kindling in mice.

Atif Ali1, Farhan Jalees Ahmad, Krishna Kolappa Pillai, Divya Vohora.   

Abstract

This study was performed to investigate whether or not amiloride, a sodium-hydrogen exchanger (NHE) inhibitor, can protect against seizure development of pentylenetetrazole (PTZ)-induced kindling in mice.Kindling was induced by once every 2 days treatment with PTZ (25 mg kg(-1) i.p.) for 5 weeks. Challenge experiments were carried out after 15 or 30 days of last treatment with PTZ. Administration of amiloride (2 h before PTZ, in doses of 0.65 and 1.3 mg kg(-1), p.o.) significantly prolonged the onset of kindling and reduced the incidence and severity of seizures in a dose-dependent manner. The effect of amiloride on the incidence of PTZ-induced seizures was evident even after 15 or 30 days of last treatment. The results indicate a protective role for amiloride against PTZ-induced kindling in mice. The possibility of mediation of such effects by NHE inhibition is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15951829      PMCID: PMC1576220          DOI: 10.1038/sj.bjp.0706291

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

Review 1.  Mechanisms of regulation of the Na+/H+ exchanger.

Authors:  S Grinstein; A Rothstein
Journal:  J Membr Biol       Date:  1986       Impact factor: 1.843

2.  A permanent change in convulsive threshold in normal and brain-damaged rats with repeated small doses of pentylenetetrazol.

Authors:  C R Mason; R M Cooper
Journal:  Epilepsia       Date:  1972-09       Impact factor: 5.864

Review 3.  Intracellular pH.

Authors:  A Roos; W F Boron
Journal:  Physiol Rev       Date:  1981-04       Impact factor: 37.312

4.  Acute pentylenetetrazol injection reduces rat GABAA receptor mRNA levels and GABA stimulation of benzodiazepine binding with No effect on benzodiazepine binding site density.

Authors:  L A Walsh; M Li; T J Zhao; T H Chiu; H C Rosenberg
Journal:  J Pharmacol Exp Ther       Date:  1999-06       Impact factor: 4.030

Review 5.  Animal models used in the screening of antiepileptic drugs.

Authors:  H Kupferberg
Journal:  Epilepsia       Date:  2001       Impact factor: 5.864

6.  Activity-dependent intracellular acidification correlates with the duration of seizure activity.

Authors:  Z Q Xiong; P Saggau; J L Stringer
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

7.  Effects of compounds acting on GABA(B) receptors in the pentylenetetrazole kindling model of epilepsy in mice.

Authors:  G De Sarro; E Palma; N Costa; R Marra; S Gratteri; A De Sarro; D Rotiroti
Journal:  Neuropharmacology       Date:  2000-08-23       Impact factor: 5.250

8.  Evidence of the antiepileptic potential of amiloride with neuropharmacological benefits in rodent models of epilepsy and behavior.

Authors:  Atif Ali; Farhan Jalees Ahmad; K K Pillai; Divya Vohora
Journal:  Epilepsy Behav       Date:  2004-06       Impact factor: 2.937

9.  Epileptiform activity induced by alkalosis in rat neocortical slices: block by antagonists of N-methyl-D-aspartate.

Authors:  J A Aram; D Lodge
Journal:  Neurosci Lett       Date:  1987-12-29       Impact factor: 3.046

10.  Effects of amiloride and its analogues on [3H]batrachotoxinin-A 20-alpha benzoate binding, [3H]tetracaine binding and 22Na influx.

Authors:  J Velly; M Grima; N Decker; E J Cragoe; J Schwartz
Journal:  Eur J Pharmacol       Date:  1988-04-27       Impact factor: 4.432

View more
  15 in total

1.  Inhibition of Acid Sensing Ion Channel 3 Aggravates Seizures by Regulating NMDAR Function.

Authors:  Qian Cao; Zhe-Man Xiao; Xi Wang; Chao Weng; Man Ding; Fan Zhu; Zu-Neng Lu
Journal:  Neurochem Res       Date:  2018-05-07       Impact factor: 3.996

2.  Anticonvulsant and antioxidant actions of trimetazidine in pentylenetetrazole-induced kindling model in mice.

Authors:  Seema Jain; Nidhi Bharal; Sonam Khurana; Pramod Kumari Mediratta; Krishna Kishore Sharma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-02-12       Impact factor: 3.000

3.  Amiloride improves locomotor recovery after spinal cord injury.

Authors:  Julieann C Durham-Lee; Venkata Usha L Mokkapati; Kathia M Johnson; Olivera Nesic
Journal:  J Neurotrauma       Date:  2011-07       Impact factor: 5.269

4.  Ferulic Acid Supplementation for Management of Depression in Epilepsy.

Authors:  Tanveer Singh; Taranjot Kaur; Rajesh Kumar Goel
Journal:  Neurochem Res       Date:  2017-06-12       Impact factor: 3.996

5.  Induction of angiopoietin-2 after spinal cord injury.

Authors:  J C Durham-Lee; Y Wu; V U L Mokkapati; A A Paulucci-Holthauzen; O Nesic
Journal:  Neuroscience       Date:  2011-10-04       Impact factor: 3.590

6.  Amiloride delays the onset of pilocarpine-induced seizures in rats.

Authors:  Prosper N'Gouemo
Journal:  Brain Res       Date:  2008-05-15       Impact factor: 3.252

7.  Proconvulsant effects of estriol, the third estrogen, in the mouse PTZ-kindling model.

Authors:  Aakifa Ahmad; Divya Vohora
Journal:  Neurol Sci       Date:  2014-04-19       Impact factor: 3.307

8.  Amiloride enhances the anticonvulsant action of various antiepileptic drugs in the mouse maximal electroshock seizure model.

Authors:  Jarogniew J Luszczki; Katarzyna M Sawicka; Justyna Kozinska; Monika Dudra-Jastrzebska; Stanislaw J Czuczwar
Journal:  J Neural Transm (Vienna)       Date:  2008-11-22       Impact factor: 3.575

9.  Acid sensing ion channel (ASIC) inhibitors exhibit anxiolytic-like activity in preclinical pharmacological models.

Authors:  Jason M Dwyer; Stacey J Sukoff Rizzo; Sarah J Neal; Qian Lin; Flora Jow; Robert L Arias; Sharon Rosenzweig-Lipson; John Dunlop; Chad E Beyer
Journal:  Psychopharmacology (Berl)       Date:  2008-10-24       Impact factor: 4.530

10.  Amiloride and SN-6 suppress audiogenic seizure susceptibility in genetically epilepsy-prone rats.

Authors:  Hillary Quansah; Prosper N'Gouemo
Journal:  CNS Neurosci Ther       Date:  2014-06-20       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.